{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:49:45Z","timestamp":1791996585652,"version":"4.4.0"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100003358","name":"Gedeon Richter","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003358","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>STUDY QUESTION<\/jats:title><jats:p>Does letrozole (LZ) co-treatment during ovarian stimulation with gonadotropins for in IVF impact follicle recruitment, oocyte number and quality, embryo quality, or live birth rate (LBR)?<\/jats:p><\/jats:sec><jats:sec><jats:title>SUMMARY ANSWER<\/jats:title><jats:p>No impact of LZ was found in follicle recruitment, number of oocytes, quality of embryos, or LBR.<\/jats:p><\/jats:sec><jats:sec><jats:title>WHAT IS KNOWN ALREADY<\/jats:title><jats:p>Multi-follicle stimulation for IVF produces supra-physiological oestradiol levels. LZ is an aromatase inhibitor that lowers serum oestradiol thus reducing negative feedback and increasing the endogenous gonadotropins in both the follicular and the luteal phases, effectively normalizing the endocrine milieu during IVF treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title><jats:p>Secondary outcomes from a randomized, double-blind placebo-controlled trial (RCT) investigating once-daily 5\u2009mg LZ or placebo during stimulation for IVF with FSH. The RCT was conducted at four fertility clinics at University Hospitals in Denmark from August 2016 to November 2018 and pregnancy outcomes of frozen-thawed embryo transfers (FET) registered until May 2023.<\/jats:p><\/jats:sec><jats:sec><jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title><jats:p>One hundred fifty-nine women with expected normal ovarian reserve (anti-M\u00fcllerian hormone 8\u201332\u2009nmol\/l) were randomized to either co-treatment with LZ (n\u2009=\u200980) or placebo (n\u2009=\u200979). In total 1268 oocytes were aspirated developing into 386 embryos, and morphology and morphokinetics were assessed. One hundred twenty-nine embryos were transferred in the fresh cycle and 158 embryos in a subsequent FET cycle. The effect of LZ on cumulative clinical pregnancy rate (CPR), LBR, endometrial thickness in the fresh cycle, and total FSH consumption was reported.<\/jats:p><\/jats:sec><jats:sec><jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title><jats:p>The proportion of usable embryos of retrieved oocytes was similar in the LZ group and the placebo group with 0.31 vs 0.36 (mean difference (MD) \u22120.05, 95% CI (\u22120.12; 0.03), P\u2009=\u20090.65). The size and number of aspirated follicles at oocyte retrieval were similar with 11.8 vs 10.3 follicles per patient (MD 1.5, 95% CI (\u22120.5; 3.1), P\u2009=\u20090.50), as well as the number of retrieved oocytes with 8.0 vs 7.9 oocytes (MD 0.1, 95% CI (\u22121.4; 1.6), P\u2009=\u20090.39) in the LZ and placebo groups, respectively. The chance of retrieving an oocyte from the 13 to 16\u2009mm follicles at trigger day was 66% higher (95% CI (24%; 108%), P\u2009=\u20090.002) in the placebo group than in the LZ group, whilst the chance of retrieving an oocyte from the \u226517\u2009mm follicles at trigger day was 50% higher (95% CI (2%; 98%), P\u2009=\u20090.04) in the LZ group than in the placebo group. The proportion of fertilized oocytes with two-pronuclei per retrieved oocytes or per metaphase II oocytes (MII) (the 2PN rates) were similar regardless of fertilization with IVF or ICSI with 0.48 vs 0.57 (MD \u22120.09, 95% CI (\u22120.24; 0.04), P\u2009=\u20090.51), and 0.62 vs 0.64 (MD \u22120.02, 95% CI (\u22120.13; 0.07), P\u2009=\u20090.78) in the LZ and placebo groups, respectively. However, the MII rate in the ICSI group was significantly lower with 0.75 vs 0.88 in the LZ vs the placebo group (MD \u22120.14, 95% CI (\u22120.22; \u22120.06), P\u2009=\u20090.03). Blastocysts on Day 5 per patient were similar with 1.5 vs 2.0, P\u2009=\u20090.52, as well as vitrified blastocysts per patient Day 5 with 0.8 vs 1.2 in (MD \u22120.4, 95% CI (\u22121.0; 0.2), P\u2009=\u20090.52) and vitrified blastocysts per patient Day 6 with 0.6 vs 0.6 (MD 0, 95% CI (\u22120.3; 0.3), P\u2009=\u20091.00) in the LZ vs placebo group, respectively. Morphologic evaluation of all usable embryos showed a similar distribution in \u2018Good\u2019, \u2018Fair\u2019, and \u2018Poor\u2019, in the LZ vs placebo group, with an odds ratio (OR) of 0.8 95% CI (0.5; 1.3), P\u2009=\u20090.68 of developing a better class embryo. Two hundred and ninety-five of the 386 embryos were cultured in an embryoscope. Morphokinetic annotations showed that the odds of having a high KIDscore\u2122 D3 Day 3 were 1.2 times higher (CI (0.8; 1.9), P\u2009=\u20090.68) in the LZ group vs the placebo group. The CPR per transfer was comparable with 31% vs 39% (risk-difference of 8%, 95% CI (\u221225%; 11%), P\u2009=\u20090.65) in the LZ and placebo group, respectively, as well as CPR per transfer adjusted for day of transfer, oestradiol and progesterone levels at trigger, progesterone levels mid-luteal, and number of oocytes retrieved (adjusted OR) of 0.8 (95% CI (0.4; 1.6), P\u2009=\u20090.72). Comparable LBR were found per transfer 28% vs 37% (MD \u22129%, 95% CI (\u221226%; 9%), P\u2009=\u20090.60) and per randomized women 24% vs 30% (MD of \u22126%, CI (\u221222%; 8%), P\u2009=\u20090.60) in the LZ group and placebo group, respectively. Furthermore, 4.8\u2009years since the last oocyte aspiration, a total of 287 of 386 embryos have been transferred in the fresh or a subsequently FET cycle, disclosing the cumulative CPR, which is similar with 38% vs 34% (MD 95% CI (8%; 16%), P\u2009=\u20090.70) in the LZ vs placebo group.<\/jats:p><\/jats:sec><jats:sec><jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title><jats:p>Both cleavage stage and blastocyst transfer and vitrification were permitted in the protocol, making it necessary to categorize their quality and pool the results. The study was powered to detect hormonal variation but not embryo or pregnancy outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title><jats:p>The similar utilization rate and quality of the embryos support the use of LZ co-treatment for IVF with specific indication as fertility preservation, patients with previous cancer, or poor responders. The effect of LZ on mature oocytes from different follicle sizes and LBRs should be evaluated in a meta-analysis or a larger RCT.<\/jats:p><\/jats:sec><jats:sec><jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title><jats:p>Funding was received from EU Interreg for ReproUnion, Sjaelland University Hospital, Denmark, Ferring Pharmaceuticals, and Gedeon Ricther. Roche Diagnostics contributed with assays. A.P. has received grants from Ferring, Merck Serono, and Gedeon Richter, consulting fees from Preglem, Novo Nordisk, Ferring, Gedeon Richter, Cryos, &amp; Merck A\/S, speakers fees from Gedeon Richter, Ferring, Merck A\/S, Theramex, &amp; Organon, and travel support from Gedeon Richter. The remaining authors declare that they have no competing interests in the research or publication.<\/jats:p><\/jats:sec><jats:sec><jats:title>TRIAL REGISTRATION NUMBERS<\/jats:title><jats:p>NCT02939898 and NCT02946684.<\/jats:p><\/jats:sec>","DOI":"10.1093\/humrep\/dead182","type":"journal-article","created":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T02:13:31Z","timestamp":1694571211000},"page":"2154-2165","source":"Crossref","is-referenced-by-count":17,"title":["Impact of letrozole co-treatment during ovarian stimulation on oocyte yield, embryo development, and live birth rate in women with normal ovarian reserve: secondary outcomes from the RIOT trial"],"prefix":"10.1093","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2005-7277","authenticated-orcid":false,"given":"Nathalie S\u00f8derhamn","family":"B\u00fclow","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Endocrinological and Reproductive Unit, Copenhagen University Hospital, Herlev Hospital , Copenhagen, Denmark"},{"name":"The Fertility Department, Rigshospitalet, Copenhagen University Hospital , Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka Katarzyna","family":"Warzecha","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Endocrinological and Reproductive Unit, Copenhagen University Hospital, Herlev Hospital , Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette Villads","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Endocrinological and Reproductive Unit, Copenhagen University Hospital, Herlev Hospital , Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7681-253X","authenticated-orcid":false,"given":"Claus Yding","family":"Andersen","sequence":"additional","affiliation":[{"name":"Faculty of Health and Medical Sciences, Institute of Clinical Medicine, University of Copenhagen , Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne Dreyer","family":"Holt","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, The Fertility Department, Zealand University Hospital K\u00f8ge , K\u00f8ge, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten R\u00f8nn","family":"Petersen","sequence":"additional","affiliation":[{"name":"The Fertility Department, Rigshospitalet, Copenhagen University Hospital , Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negjyp","family":"Sopa","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, The Fertility Clinic, Copenhagen University Hospital , Hvidovre, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Zedeler","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, The Fertility Clinic, Copenhagen University Hospital , Hvidovre, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Lis","family":"Englund","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, The Fertility Department, Zealand University Hospital K\u00f8ge , K\u00f8ge, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8340-104X","authenticated-orcid":false,"given":"Anja","family":"Pinborg","sequence":"additional","affiliation":[{"name":"The Fertility Department, Rigshospitalet, Copenhagen University Hospital , Copenhagen, Denmark"},{"name":"Department of Obstetrics and Gynaecology, The Fertility Clinic, Copenhagen University Hospital , Hvidovre, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8339-4786","authenticated-orcid":false,"given":"Marie Louise","family":"Gr\u00f8ndahl","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Endocrinological and Reproductive Unit, Copenhagen University Hospital, Herlev Hospital , Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven Olaf","family":"Skouby","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Endocrinological and Reproductive Unit, Copenhagen University Hospital, Herlev Hospital , Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas Stephen","family":"Macklon","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, The Fertility Department, Zealand University Hospital K\u00f8ge , K\u00f8ge, Denmark"},{"name":"London Women\u2019s Clinic , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,9,12]]},"reference":[{"key":"2023110708005861100_dead182-B1","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1007\/s43032-021-00564-9","article-title":"Embryo morphokinetics and blastocyst development after GnRH agonist versus hCG triggering in normo-ovulatory women: a secondary analysis of a multicenter randomized controlled trial","volume":"28","author":"Alexopoulou","year":"2021","journal-title":"Reprod Sci"},{"key":"2023110708005861100_dead182-B2","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/humrep\/der037","article-title":"The Istanbul Consensus Workshop on embryo assessment: proceedings of an expert meeting","volume":"26","author":"Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology","year":"2011","journal-title":"Hum Reprod"},{"key":"2023110708005861100_dead182-B3","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.fertnstert.2007.05.003","article-title":"Increased intrafollicular androgen levels affect human granulosa cell secretion of anti-M\u00fcllerian hormone and inhibin-B","volume":"89","author":"Andersen","year":"2008","journal-title":"Fertil Steril"},{"key":"2023110708005861100_dead182-B4","first-page":"1820","article-title":"Short-term androgen priming by use of aromatase inhibitor and hCG before controlled ovarian stimulation for IVF. A randomized controlled trial","volume":"138","author":"Anderson","year":"2009","journal-title":"Reproduction"},{"key":"2023110708005861100_dead182-B5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc B"},{"key":"2023110708005861100_dead182-B6","doi-asserted-by":"crossref","first-page":"574669","DOI":"10.3389\/fonc.2020.574669","article-title":"Efficacy and safety of controlled ovarian stimulation with or without letrozole co-administration for fertility preservation: a systematic review and meta-analysis","volume":"10","author":"Bonardi","year":"2020","journal-title":"Front Oncol"},{"key":"2023110708005861100_dead182-B7","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.fertnstert.2009.10.044","article-title":"Ovarian stimulation for in vitro fertilization alters the intrauterine cytokine, chemokine, and growth factor milieu encountered by the embryo","volume":"94","author":"Boomsma","year":"2010","journal-title":"Fertil Steril"},{"key":"2023110708005861100_dead182-B8","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.rbmo.2021.12.006","article-title":"Co-treatment with letrozole during ovarian stimulation for IVF\/ICSI: a systematic review and meta-analysis","volume":"44","author":"B\u00fclow","year":"2022","journal-title":"Reprod Biomed Online"},{"key":"2023110708005861100_dead182-B9","first-page":"deab249","article-title":"Impact of letrozole co-treatment during ovarian stimulation with gonadotrophins for IVF: a multicentre, randomized, double-blinded placebo-controlled trial","volume":"32","author":"B\u00fclow","year":"2021","journal-title":"Hum Reprod"},{"key":"2023110708005861100_dead182-B10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4103\/0974-1208.142479","article-title":"Follicular steroid hormones as markers of oocyte quality and oocyte development potential","volume":"7","author":"Carpintero","year":"2014","journal-title":"J Hum Reprod Sci"},{"key":"2023110708005861100_dead182-B11","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1590\/S0100-879X2004001100021","article-title":"Estradiol and testosterone concentrations in follicular fluid as criteria to discriminate between mature and immature oocytes","volume":"37","author":"Costa","year":"2004","journal-title":"Braz J Med Biol Res"},{"key":"2023110708005861100_dead182-B12","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1028-4559(10)60064-2","article-title":"GnRH antagonist\/letrozole versus microdose GnRH agonist flare protocol in poor responders undergoing in vitro fertilization","volume":"49","author":"Davar","year":"2010","journal-title":"Taiwan J Obstet Gynecol"},{"key":"2023110708005861100_dead182-B13","first-page":"131","article-title":"Randomized controlled trial comparing embryonic quality in rFSH versus hMG in the IVF protocol with GnRH antagonist","volume":"25","author":"de Chapon","year":"2021","journal-title":"JBRA Assist Reprod"},{"key":"2023110708005861100_dead182-B14","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0015-0282(01)03062-X","article-title":"Effects of exogenous estrogen on uterine leukocyte recruitment","volume":"77","author":"DeLoia","year":"2002","journal-title":"Fertil Steril"},{"key":"2023110708005861100_dead182-B15","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.fertnstert.2007.04.027","article-title":"Endometrial thickness is related to miscarriage rate, but not to the estradiol concentration, in cycles down-regulated with gonadotropin-releasing hormone antagonist","volume":"89","author":"Detti","year":"2008","journal-title":"Fertil Steril"},{"key":"2023110708005861100_dead182-B16","first-page":"dgac409","article-title":"The impact of suppressing estradiol during ovarian stimulation on the unsupported luteal phase: a RCT","volume":"106","author":"Dreyer Holt","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2023110708005861100_dead182-B17","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3109\/09513590.2015.1110133","article-title":"Controlled ovarian hyperstimulation with sequential letrozole co-treatment in normo\/high responders","volume":"32","author":"Ecemis","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"2023110708005861100_dead182-B18","first-page":"287","article-title":"Effect of adding letrozole to gonadotropin on in vitro fertilization outcomes: An RCT","volume":"18","author":"Eftekhar","year":"2020","journal-title":"Int J Reprod Biomed"},{"key":"2023110708005861100_dead182-B19","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1093\/humrep\/16.9.1970","article-title":"The Graduated Embryo Score (GES) predicts blastocyst formation and pregnancy rate from cleavage-stage embryos","volume":"16","author":"Fisch","year":"2001","journal-title":"Hum Reprod"},{"key":"2023110708005861100_dead182-B20","first-page":"218","article-title":"Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome","volume":"113","author":"Franik","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"2023110708005861100_dead182-B21","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.rbmo.2018.08.025","article-title":"Optimal endometrial thickness to maximize live births and minimize pregnancy losses: analysis of 25,767 fresh embryo transfers","volume":"37","author":"Gallos","year":"2018","journal-title":"Reprod Biomed Online"},{"key":"2023110708005861100_dead182-B22","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/humupd\/3.4.367","article-title":"Culture and selection of viable blastocysts: a feasible proposition for human IVF?","volume":"3","author":"Gardner","year":"1997","journal-title":"Hum Reprod Update"},{"key":"2023110708005861100_dead182-B23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1023\/A:1022543901455","article-title":"Human embryo viability: what determines developmental potential, and can it be assessed?","volume":"15","author":"Gardner","year":"1998","journal-title":"J Assist Reprod Genet"},{"key":"2023110708005861100_dead182-B24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.fertnstert.2011.04.033","article-title":"Human cumulus cell gene expression as a biomarker of pregnancy outcome after single embryo transfer","volume":"96","author":"Gebhardt","year":"2011","journal-title":"Fertil Steril"},{"issue":"6","key":"2023110708005861100_dead182-B25","first-page":"CD002118","article-title":"Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology","author":"Glujovsky","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2023110708005861100_dead182-B26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12958-018-0443-x","article-title":"Letrozole-associated controlled ovarian hyperstimulation in breast cancer patients versus conventional controlled ovarian hyperstimulation in infertile patients: assessment of oocyte quality related biomarkers","volume":"17","author":"Goldrat","year":"2019","journal-title":"Reprod Biol Endocrinol"},{"key":"2023110708005861100_dead182-B27","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/humrep\/deh359","article-title":"A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report","volume":"19","author":"Goswami","year":"2004","journal-title":"Hum Reprod"},{"key":"2023110708005861100_dead182-B28","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12958-017-0288-8","article-title":"Does daily co-administration of letrozole and gonadotropins during ovarian stimulation improve IVF outcome?","volume":"15","author":"Haas","year":"2017","journal-title":"Reprod Biol Endocrinol"},{"key":"2023110708005861100_dead182-B29","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.fertnstert.2017.08.017","article-title":"In vitro fertilization treatments with the use of clomiphene citrateor letrozole","volume":"108","author":"Haas","year":"2017","journal-title":"Fertil Steril"},{"key":"2023110708005861100_dead182-B30","volume-title":"Towards Reproductive Certainty: Fertility and Genetics beyond 1999: The Plenary Proceedings of the 11th World Congress","author":"Jansen","year":"1999"},{"key":"2023110708005861100_dead182-B31","doi-asserted-by":"crossref","first-page":"E1524","DOI":"10.1210\/jc.2012-1427","article-title":"LH-receptor gene expression in human granulosa and cumulus cells from antral and preovulatory follicles","volume":"97","author":"Jeppesen","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2023110708005861100_dead182-B32","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00404-022-06676-0","article-title":"Effects of letrozole co-treatment on outcomes of gonadotropin-releasing hormone antagonist cycles in POSEIDON groups 3 and 4 expected poor responders","volume":"306","author":"Kahraman","year":"2022","journal-title":"Arch Gynecol Obstet"},{"key":"2023110708005861100_dead182-B33","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.rbmo.2011.05.012","article-title":"Sequential use of letrozole and gonadotrophin in women with poor ovarian reserve: a randomized controlled trial","volume":"23","author":"Lee","year":"2011","journal-title":"Reprod Biomed Online"},{"key":"2023110708005861100_dead182-B34","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.rbmo.2017.04.010","article-title":"High oestradiol concentration after ovarian stimulation is associated with lower maternal serum beta-HCG concentration and neonatal birth weight","volume":"35","author":"Liu","year":"2017","journal-title":"Reprod Biomed Online"},{"key":"2023110708005861100_dead182-B35","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3389\/fendo.2020.00627","article-title":"Biological and clinical rationale for androgen priming in ovarian stimulation","volume":"11","author":"Lossl","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2023110708005861100_dead182-B36","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1210\/er.2005-0015","article-title":"The science behind 25 years of ovarian stimulation for in vitro fertilization","volume":"27","author":"Macklon","year":"2006","journal-title":"Endocr Rev"},{"key":"2023110708005861100_dead182-B37","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.fertnstert.2021.12.025","article-title":"Optimal endometrial thickness in fresh and frozen-thaw in vitro fertilization cycles: an analysis of live birth rates from 96,000 autologous embryo transfers","volume":"117","author":"Mahutte","year":"2022","journal-title":"Fertil Steril"},{"key":"2023110708005861100_dead182-B38","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/humrep\/deaa029","article-title":"Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer-a prospective nationwide Swedish multicenter study","volume":"35","author":"Marklund","year":"2020","journal-title":"Hum Reprod"},{"key":"2023110708005861100_dead182-B39","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1093\/humrep\/deh535","article-title":"Human cumulus granulosa cell gene expression: a predictor of fertilization and embryo selection in women undergoing IVF","volume":"19","author":"McKenzie","year":"2004","journal-title":"Hum Reprod"},{"key":"2023110708005861100_dead182-B40","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0015-0282(00)01705-2","article-title":"Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate","volume":"75","author":"Mitwally","year":"2001","journal-title":"Fertil Steril"},{"key":"2023110708005861100_dead182-B41","doi-asserted-by":"crossref","first-page":"166","DOI":"10.5539\/gjhs.v8n4p166","article-title":"Comparison of GnRh agonist microdose flare up and GnRh antagonist\/letrozole in treatment of poor responder patients in intra cytoplaspic sperm injection: randomized clinical trial","volume":"8","author":"Nabati","year":"2015","journal-title":"Glob J Health Sci"},{"key":"2023110708005861100_dead182-B42","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/molehr\/gaq073","article-title":"In human granulosa cells from small antral follicles, androgen receptor mRNA and androgen levels in follicular fluid correlate with FSH receptor mRNA","volume":"17","author":"Nielsen","year":"2011","journal-title":"Mol Hum Reprod"},{"key":"2023110708005861100_dead182-B43","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1210\/jc.2006-0962","article-title":"Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy","volume":"91","author":"Oktay","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2023110708005861100_dead182-B44","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.rbmo.2009.05.007","article-title":"Use of aromatase inhibitors in poor-responder patients receiving GnRH antagonist protocols","volume":"19","author":"Ozmen","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"2023110708005861100_dead182-B45","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/humrep\/dew188","article-title":"Development of a generally applicable morphokinetic algorithm capable of predicting the implantation potential of embryos transferred on Day 3","volume":"31","author":"Petersen","year":"2016","journal-title":"Hum Reprod"},{"key":"2023110708005861100_dead182-B46","doi-asserted-by":"crossref","first-page":"deac119","DOI":"10.1093\/humrep\/deac119","article-title":"Effects of letrozole cotreatment on endocrinology and follicle development in women undergoing ovarian stimulation in an antagonist protocol","volume":"37","author":"Poulsen","year":"2022","journal-title":"Hum Reprod"},{"key":"2023110708005861100_dead182-B47","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1477-7827-7-40","article-title":"Follicular fluid content and oocyte quality: from single biochemical markers to metabolomics","volume":"7","author":"Revelli","year":"2009","journal-title":"Reprod Biol Endocrinol"},{"key":"2023110708005861100_dead182-B48","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0015-0282(16)55105-X","article-title":"Is there any correlation between follicular fluid hormone concentrations, fertilizability, and cytogenetic analysis of human oocytes recovered for in vitro fertilization?","volume":"57","author":"Rosenbusch","year":"1992","journal-title":"Fertil Steril"},{"key":"2023110708005861100_dead182-B49","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Hum Reprod"},{"key":"2023110708005861100_dead182-B50","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/j.bbadis.2012.05.013","article-title":"Molecular control of oogenesis","volume":"1822","author":"S\u00e1nchez","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"2023110708005861100_dead182-B51","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s10815-020-02030-y","article-title":"Effects of letrozole or tamoxifen coadministered with a standard stimulation protocol on fertility preservation among breast cancer patients","volume":"38","author":"Shulman","year":"2021","journal-title":"J Assist Reprod Genet"},{"key":"2023110708005861100_dead182-B52","first-page":"1602","article-title":"nternational evidence-based guideline for the assessment and management of polycystic ovary syndrome 2018","volume-title":"Hum Reprod","author":"Teede"},{"key":"2023110708005861100_dead182-B53","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/1933719117728800","article-title":"Ovarian stimulation in patients with cancer: impact of letrozole and BRCA mutations on fertility preservation cycle outcomes","volume":"25","author":"Turan","year":"2018","journal-title":"Reprod Sci"},{"key":"2023110708005861100_dead182-B54","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S1472-6483(10)60611-6","article-title":"Aromatase inhibitors in ovarian stimulation for IVF\/ICSI: a pilot study","volume":"13","author":"Verpoest","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"2023110708005861100_dead182-B55","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/humrep\/deu044","article-title":"Gonadotrophin stimulation for in vitro fertilization significantly alters the hormone milieu in follicular fluid: a comparative study between natural cycle IVF and conventional IVF","volume":"29","author":"von Wolff","year":"2014","journal-title":"Hum Reprod"},{"key":"2023110708005861100_dead182-B56","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1177\/0300060518770346","article-title":"Comparison of modified agonist, mild-stimulation and antagonist protocols for in vitro fertilization in patients with diminished ovarian reserve","volume":"46","author":"Yu","year":"2018","journal-title":"J Int Med Res"},{"key":"2023110708005861100_dead182-B57","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1093\/humrep\/dem221","article-title":"Influence of ovarian stimulation with HP-hMG or recombinant FSH on embryo quality parameters in patients undergoing IVF","volume":"22","author":"Ziebe","year":"2007","journal-title":"Hum Reprod"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/38\/11\/2154\/52726845\/dead182.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/38\/11\/2154\/52726845\/dead182.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,27]],"date-time":"2024-10-27T11:19:15Z","timestamp":1730027955000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/38\/11\/2154\/7271790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,12]]},"references-count":57,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,9,12]]},"published-print":{"date-parts":[[2023,11,2]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/dead182","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,11,1]]},"published":{"date-parts":[[2023,9,12]]}}}